Viemed Healthcare, Inc. provides durable home medical equipment and post-acute respiratory health care services to patients in the United States. The company is headquartered in Lafayette, Louisiana.
| Revenue (TTM) | $286.56M |
| Gross Profit (TTM) | $165.01M |
| EBITDA | $54.62M |
| Operating Margin | 6.27% |
| Return on Equity | 10.90% |
| Return on Assets | 8.32% |
| Revenue/Share (TTM) | $7.42 |
| Book Value | $3.72 |
| Price-to-Book | 3.21 |
| Price-to-Sales (TTM) | 1.61 |
| EV/Revenue | 1.62 |
| EV/EBITDA | 8.76 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 27.50% |
| Shares Outstanding | $38.34M |
| Float | $30.27M |
| % Insiders | 13.67% |
| % Institutions | 68.96% |
Volatility is currently expanding
Dallas, Texas--(Newsfile Corp. - May 12, 2026) - Viemed Healthcare, Inc. (NASDAQ: VMD). Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (NASDAQ: VMD).
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Viemed Healthcare, Inc. (VMD) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.06 per share a year ago.
LAFAYETTE, LA / ACCESS Newswire / May 5, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three months ended March 31, 2026, and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025.
